1. Anti‐Müllerian hormone, a Sertoli cell‐derived marker, is decreased in plasma of male patients in all stages of chronic kidney disease. (9th October 2015) Authors: Eckersten, D.; Giwercman, A.; Bruun, L.; Christensson, A. Journal: Andrology Issue: Volume 3:Number 6(2015) Page Start: 1160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between semen parameters and chance of fatherhood ‐ a long‐term follow‐up study. (7th December 2018) Authors: Malm, G.; Rylander, L.; Giwercman, A.; Haugen, T. B. Journal: Andrology Issue: Volume 7:Number 1(2019) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Environmental exposures and sperm quality in human populations. (10th October 2016) Authors: Giwercman, A. Journal: Toxicology letters Issue: Volume 259(2016)Supplement Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia. (1st August 2018) Authors: Colpi, G. M.; Francavilla, S.; Haidl, G.; Link, K.; Behre, H. M.; Goulis, D. G.; Krausz, C.; Giwercman, A. Journal: Andrology Issue: Volume 6:Number 4(2018) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evidence for decreasing quality of semen during past 50 years. Issue 6854 (12th September 1992) Authors: Carlsen, E.; Giwercman, A.; Keiding, N.; Skakkebaek, N. E. Journal: BMJ Issue: Volume 305:Issue 6854(1992) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High risk of hypogonadism in young male cancer survivors. (10th January 2018) Authors: Isaksson, S.; Bogefors, K.; Ståhl, O.; Eberhard, J.; Giwercman, Y.L.; Leijonhufvud, I.; Link, K.; Øra, I.; Romerius, P.; Bobjer, J.; Giwercman, A. Journal: Clinical endocrinology Issue: Volume 88:Number 3(2018) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome. (23rd May 2017) Authors: Bogefors, C.; Isaksson, S.; Bobjer, J.; Kitlinski, M.; Leijonhufvud, I.; Link, K.; Giwercman, A. Journal: Andrology Issue: Volume 5:Number 4(2017:Jul.) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of antioxidant treatment on DNA fragmentation index: a double‐blind placebo‐controlled randomized trial. (8th October 2018) Authors: Stenqvist, A.; Oleszczuk, K.; Leijonhufvud, I.; Giwercman, A. Journal: Andrology Issue: Volume 6:Number 6(2018) Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. In Memoriam: Marcello Spanò: 1954 – 2017. (10th March 2017) Authors: Bonde, J. P.; Giwercman, A. Journal: Andrology Issue: Volume 5:Number 2(2017:Mar.) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Inhibin B concentration is predictive for long‐term azoospermia in men treated for testicular cancer. (12th February 2014) Authors: Isaksson, S.; Eberhard, J.; Ståhl, O.; Cavallin‐Ståhl, E.; Cohn‐Cedermark, G.; Arver, S.; Lundberg Giwercman, Y.; Giwercman, A. Journal: Andrology Issue: Volume 2:Number 2(2014) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗